Biotech startup Immuneel Therapeutics raised $15Mn in Series A led by Eight Roads Ventures & others


Biotech startup Immuneel Therapeutics raised $15 million in Series A led by Eight Roads Ventures, True North Fund VI LLP and F-Prime Capital, where other existing investors also participated.


Immuneel provides cancer patients with cell and gene therapy programmes. The funding will also enable us to continue building a dedicated and quality enterprise for global innovators to consider partnering with us: Immuneel cofounder. The funds will be used to expand the startup's operations and advance its development pipeline.

10 views0 comments